Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,836 | 6 | 83.0% |
| Travel and Lodging | $5,616 | 12 | 14.6% |
| Food and Beverage | $920.29 | 20 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $22,671 | 25 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $8,692 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $7,009 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $5,934 | 7 | Janssen Pharmaceuticals, Inc ($5,934) |
| 2018 | $8,692 | 7 | Janssen Scientific Affairs, LLC ($8,692) |
| 2017 | $23,747 | 24 | Janssen Pharmaceuticals, Inc ($16,737) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $623.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | Cash or cash equivalent | $79.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $5,100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $6,700.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Travel and Lodging | Cash or cash equivalent | $1,362.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $389.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2018 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/20/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $5,601.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $609.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | Cash or cash equivalent | $166.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/14/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $779.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 13 | $2,157 | $1,691 |
| 2022 | 2 | 31 | 42 | $4,655 | $3,334 |
| 2021 | 1 | 11 | 14 | $140.00 | $42.00 |
| 2020 | 4 | 55 | 61 | $4,289 | $3,238 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $2,157 | $1,691 | 78.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 26 | $4,337 | $3,154 | 72.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 16 | $318.72 | $180.11 | 56.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 14 | $140.00 | $42.00 | 30.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 20 | $3,336 | $2,577 | 77.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 12 | 12 | $514.32 | $388.15 | 75.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 15 | $298.80 | $230.69 | 77.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 13 | 14 | $140.00 | $41.94 | 30.0% |
About Dr. Michael Siegal, MD
Dr. Michael Siegal, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659434520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Siegal, MD has received a total of $38,372 in payments from pharmaceutical and medical device companies, with $5,934 received in 2019. These payments were reported across 38 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($31,836).
As a Medicare-enrolled provider, Siegal has provided services to 108 Medicare beneficiaries, totaling 130 services with total Medicare billing of $8,306. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 12/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659434520
Products in Payments
- INVOKANA (Drug) $31,363
- SERELAXIN (Drug) $7,009
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054